FDA Import Refusal SCS-1442909-8/11/1 — Tianjin Kingyork Pharmaceuticals Co., Ltd
The FDA refused shipment SCS-1442909-8/11/1 from Tianjin Kingyork Pharmaceuticals Co., Ltd (China) on Oct 9, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 3 other import refusals on record.
Refusal details
- Date
- Oct 9, 2020
- Country
- China
- Product Category
- Drugs and Biologics
- Product Code
- 66VDY99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75